Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
7.35
Dollar change
+0.65
Percentage change
9.70
%
Index- P/E- EPS (ttm)-0.99 Insider Own22.69% Shs Outstand31.45M Perf Week5.00%
Market Cap288.12M Forward P/E- EPS next Y-0.29 Insider Trans1.51% Shs Float30.31M Perf Month20.89%
Income-31.91M PEG- EPS next Q-0.14 Inst Own31.84% Short Float8.11% Perf Quarter5.00%
Sales135.81M P/S2.12 EPS this Y54.65% Inst Trans-2.27% Short Ratio2.86 Perf Half Y88.46%
Book/sh-0.37 P/B- EPS next Y59.55% ROA-77.78% Short Interest2.46M Perf Year297.30%
Cash/sh0.39 P/C18.84 EPS next 5Y- ROE-719.95% 52W Range1.14 - 9.11 Perf YTD-11.34%
Dividend Est.- P/FCF254.97 EPS past 5Y-61.17% ROI-504.36% 52W High-19.32% Beta1.36
Dividend TTM- Quick Ratio0.65 Sales past 5Y106.52% Gross Margin81.74% 52W Low544.74% ATR (14)0.44
Dividend Ex-Date- Current Ratio0.77 EPS Y/Y TTM44.75% Oper. Margin-14.12% RSI (14)63.57 Volatility7.37% 6.37%
Employees220 Debt/Eq- Sales Y/Y TTM14.77% Profit Margin-23.49% Recom1.00 Target Price10.60
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q23.19% Payout- Rel Volume0.46 Prev Close6.70
Sales Surprise0.45% EPS Surprise-130.68% Sales Q/Q22.93% EarningsNov 08 AMC Avg Volume859.02K Price7.35
SMA2019.26% SMA509.46% SMA20040.47% Trades Volume392,214 Change9.70%
Date Action Analyst Rating Change Price Target Change
Nov-30-23Initiated Craig Hallum Buy $10
Jul-21-23Initiated Cantor Fitzgerald Overweight $7
Jul-03-23Initiated H.C. Wainwright Buy $9
Mar-10-22Initiated Colliers Securities Buy $14
Oct-04-21Resumed B. Riley Securities Buy $16
Feb-15-24 08:00AM
Jan-31-24 08:00AM
Jan-22-24 04:15PM
Jan-18-24 08:00AM
Jan-08-24 08:00AM
05:11PM Loading…
Jan-04-24 05:11PM
12:23PM
Dec-26-23 04:05PM
Dec-13-23 05:22PM
06:01AM
06:00AM
Dec-07-23 08:00AM
Dec-05-23 10:25AM
Nov-10-23 08:00AM
Nov-08-23 04:05PM
08:00AM Loading…
08:00AM
Oct-25-23 08:00AM
Oct-09-23 09:55AM
Oct-03-23 06:00AM
Sep-27-23 08:00AM
Sep-26-23 08:00AM
Sep-21-23 06:00AM
Aug-30-23 08:00AM
Aug-15-23 10:20AM
Aug-09-23 04:05PM
Aug-02-23 08:00AM
Jul-26-23 08:00AM
Jul-23-23 05:24AM
Jun-27-23 04:30PM
06:00AM
08:00AM Loading…
Jun-20-23 08:00AM
May-23-23 08:00AM
May-12-23 07:30AM
May-09-23 07:15AM
May-08-23 08:00AM
May-03-23 08:00AM
Apr-24-23 08:00AM
Mar-28-23 08:00AM
Mar-22-23 04:05PM
08:00AM
Mar-07-23 08:00AM
Feb-10-23 08:00AM
Jan-04-23 08:00AM
Dec-27-22 08:00AM
Nov-22-22 08:00AM
Nov-18-22 04:05PM
Nov-10-22 04:05PM
Oct-26-22 08:00AM
Sep-27-22 08:00AM
Sep-20-22 08:00AM
Sep-14-22 08:00AM
Aug-22-22 08:00AM
Aug-16-22 03:00PM
Aug-11-22 04:05PM
Aug-07-22 08:42AM
Jul-27-22 08:00AM
Jul-19-22 08:00AM
Jun-27-22 04:05PM
May-16-22 01:20PM
May-14-22 08:47AM
May-13-22 07:30AM
May-02-22 08:00AM
Apr-28-22 08:00AM
Apr-07-22 08:00AM
Mar-25-22 08:00AM
Mar-23-22 08:00AM
Mar-15-22 08:00AM
Mar-07-22 04:05PM
Feb-22-22 08:00AM
Feb-15-22 09:00AM
08:00AM
Feb-03-22 08:00AM
Feb-01-22 07:48AM
Jan-28-22 10:07AM
Jan-27-22 08:00AM
Jan-21-22 05:38PM
Jan-19-22 08:00AM
Jan-18-22 08:00AM
07:30AM
Jan-12-22 08:00AM
Jan-04-22 04:05PM
Dec-30-21 08:00AM
08:00AM
Dec-23-21 08:00AM
Dec-01-21 04:48AM
Nov-16-21 04:05PM
Nov-15-21 10:22AM
Nov-10-21 04:05PM
Nov-08-21 08:00AM
Nov-02-21 04:05PM
Oct-26-21 08:00AM
Oct-04-21 04:02PM
04:01PM
Sep-30-21 07:20AM
Sep-29-21 07:20AM
Sep-28-21 04:02PM
04:01PM
Sep-21-21 08:00AM
Sep-16-21 06:37AM
Sep-13-21 08:30AM
LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The firm combines virtual medical treatment with prescription medications and over-the-counter products. It operates through the Telehealth and WorkSimpli segments. The company was founded in 1987 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jindal PiyushDirectorNov 06Option Exercise2.5237,50094,500337,500Nov 08 11:23 AM
Velge BertrandDirectorAug 31Buy3.9360,000235,800349,482Aug 31 07:00 PM
Velge BertrandDirectorAug 30Buy3.7640,000150,400289,482Aug 31 07:00 PM
Velge BertrandDirectorAug 29Buy3.5832,072114,818249,482Aug 31 07:00 PM
Benathen Marc DavidChief Financial OfficerJul 11Option Exercise0.0025,0000227,554Jul 13 12:02 PM
Alvarez Nicholas PChief Acquisition OfficerJun 14Buy2.9210,71231,279180,000Jun 15 10:16 AM
Velge BertrandDirectorJun 14Buy2.943,94511,580212,310Jun 15 12:54 PM
Velge BertrandDirectorJun 13Buy2.6444,365116,933208,365Jun 14 08:55 AM
Yecies Eric HaroldGeneral Counsel & CCOJun 13Buy2.6011,50029,90062,500Jun 14 08:33 AM
Velge BertrandDirectorJun 07Buy2.1924,50053,547164,000Jun 14 08:55 AM
Velge BertrandDirectorJun 06Buy2.18129,117281,398139,500Jun 07 05:27 PM
Velge BertrandDirectorJun 05Buy2.1710,38322,48010,383Jun 07 05:27 PM
Roberts Brad MichaelChief Operating OfficerMay 26Buy2.1930,00065,70697,632May 30 03:30 PM
Schreiber JustinCEOMay 23Buy2.0632,33666,6122,844,620May 24 09:16 AM
Galluppi StefanChief Innovation OfficerMay 23Buy2.1710,00021,70017,841May 23 03:28 PM
Schreiber JustinCEOMay 22Buy2.1517,66438,0132,812,284May 24 09:16 AM